The Sentinel Initiative, an active medical product surveillance system, was established in response to the Food and Drug Administration (FDA) Amendments Act of 2007 and has become one of the Agency’s premier evidence generation platforms.
The 12th Annual Sentinel Initiative Public Workshop is being convened on October 14, 2020 by the Robert J. Margolis, MD, Center for Health Policy under a cooperative agreement with the FDA. The online workshop provides an opportunity to discuss recent achievements and engage with the broader community of patients, consumers, and scientific stakeholders.
If you have any questions or concerns, please email email@example.com.
Funding for this conference was made possible by a cooperative agreement from the Food and Drug Administration, Center for Drug Evaluation and Research. The views expressed in written conference materials and the speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does mention of trade names, commercial practices, or organizations imply endorsements by the U.S. Government.
Further event information and materials are available here.